Atomistry » Vanadium » PDB 7q0v-9f6c » 9f6c
Atomistry »
  Vanadium »
    PDB 7q0v-9f6c »
      9f6c »

Vanadium in PDB 9f6c: Cardiac Myosin Motor Domain in the Pre-Powerstroke State Co- Crystallized with the Inhibitor Aficamten

Protein crystallography data

The structure of Cardiac Myosin Motor Domain in the Pre-Powerstroke State Co- Crystallized with the Inhibitor Aficamten, PDB code: 9f6c was solved by J.Robert-Paganin, J.J.Hartman, B.P.Morgan, F.I.Malik, A.Houdusse, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 46.60 / 2.33
Space group P 1 21 1
Cell size a, b, c (Å), α, β, γ (°) 69.424, 128.326, 103.53, 90, 91.47, 90
R / Rfree (%) 20.5 / 24.4

Other elements in 9f6c:

The structure of Cardiac Myosin Motor Domain in the Pre-Powerstroke State Co- Crystallized with the Inhibitor Aficamten also contains other interesting chemical elements:

Magnesium (Mg) 2 atoms

Vanadium Binding Sites:

The binding sites of Vanadium atom in the Cardiac Myosin Motor Domain in the Pre-Powerstroke State Co- Crystallized with the Inhibitor Aficamten (pdb code 9f6c). This binding sites where shown within 5.0 Angstroms radius around Vanadium atom.
In total 2 binding sites of Vanadium where determined in the Cardiac Myosin Motor Domain in the Pre-Powerstroke State Co- Crystallized with the Inhibitor Aficamten, PDB code: 9f6c:
Jump to Vanadium binding site number: 1; 2;

Vanadium binding site 1 out of 2 in 9f6c

Go back to Vanadium Binding Sites List in 9f6c
Vanadium binding site 1 out of 2 in the Cardiac Myosin Motor Domain in the Pre-Powerstroke State Co- Crystallized with the Inhibitor Aficamten


Mono view


Stereo pair view

A full contact list of Vanadium with other atoms in the V binding site number 1 of Cardiac Myosin Motor Domain in the Pre-Powerstroke State Co- Crystallized with the Inhibitor Aficamten within 5.0Å range:
probe atom residue distance (Å) B Occ
A:V1005

b:53.9
occ:1.00
V A:VO41005 0.0 53.9 1.0
O2 A:VO41005 1.6 50.3 1.0
O4 A:VO41005 1.6 43.9 1.0
O1 A:VO41005 1.6 48.4 1.0
O3 A:VO41005 1.6 61.2 1.0
O3B A:ADP1004 2.4 40.9 1.0
PB A:ADP1004 3.5 49.0 1.0
MG A:MG1002 3.5 53.1 1.0
O2B A:ADP1004 3.6 47.5 1.0
N A:SER242 3.7 47.2 1.0
OG A:SER241 3.7 58.7 1.0
OG A:SER180 3.8 59.6 1.0
ND2 A:ASN238 3.8 35.5 1.0
CA A:SER180 4.0 51.8 1.0
O A:HOH1101 4.0 44.3 1.0
N A:GLY464 4.1 50.1 1.0
CA A:SER241 4.1 44.3 1.0
N A:GLY181 4.2 50.6 1.0
CB A:SER180 4.3 52.6 1.0
NZ A:LYS184 4.3 39.5 1.0
CB A:SER241 4.3 46.9 1.0
C A:SER241 4.4 51.0 1.0
O1B A:ADP1004 4.4 48.3 1.0
OG A:SER242 4.4 56.6 1.0
CB A:SER242 4.4 47.2 1.0
O A:SER242 4.4 50.7 1.0
CA A:SER242 4.6 46.6 1.0
O A:HOH1105 4.6 46.5 1.0
O3A A:ADP1004 4.6 49.6 1.0
C A:SER180 4.6 55.5 1.0
CE A:LYS184 4.7 39.9 1.0
CA A:GLY464 4.8 50.3 1.0
CA A:ALA463 4.8 49.0 1.0
CG A:ASN238 4.8 49.2 1.0
CB A:ASN238 4.9 47.5 1.0
C A:ALA463 5.0 53.4 1.0
C A:SER242 5.0 52.5 1.0

Vanadium binding site 2 out of 2 in 9f6c

Go back to Vanadium Binding Sites List in 9f6c
Vanadium binding site 2 out of 2 in the Cardiac Myosin Motor Domain in the Pre-Powerstroke State Co- Crystallized with the Inhibitor Aficamten


Mono view


Stereo pair view

A full contact list of Vanadium with other atoms in the V binding site number 2 of Cardiac Myosin Motor Domain in the Pre-Powerstroke State Co- Crystallized with the Inhibitor Aficamten within 5.0Å range:
probe atom residue distance (Å) B Occ
B:V804

b:58.3
occ:1.00
V B:VO4804 0.0 58.3 1.0
O1 B:VO4804 1.6 52.5 1.0
O2 B:VO4804 1.6 54.7 1.0
O4 B:VO4804 1.6 50.0 1.0
O3 B:VO4804 1.6 65.1 1.0
O3B B:ADP803 2.5 50.2 1.0
MG B:MG801 3.4 53.7 1.0
PB B:ADP803 3.4 50.0 1.0
O2B B:ADP803 3.5 48.2 1.0
N B:SER242 3.8 49.8 1.0
OG B:SER241 3.8 63.5 1.0
OG B:SER180 3.8 68.5 1.0
N B:GLY464 3.9 57.2 1.0
ND2 B:ASN238 4.0 60.1 1.0
CA B:SER180 4.0 50.9 1.0
O B:HOH901 4.1 46.5 1.0
CB B:SER180 4.2 55.7 1.0
O1B B:ADP803 4.2 47.7 1.0
NZ B:LYS184 4.2 41.6 1.0
CA B:SER241 4.2 53.3 1.0
N B:GLY181 4.3 50.0 1.0
O B:HOH912 4.4 50.9 1.0
O B:SER242 4.4 53.1 1.0
CB B:SER242 4.4 51.1 1.0
OG B:SER242 4.5 62.1 1.0
CB B:SER241 4.5 56.6 1.0
C B:SER241 4.5 54.2 1.0
CE B:LYS184 4.6 39.8 1.0
CA B:SER242 4.6 48.3 1.0
CA B:GLY464 4.6 56.4 1.0
C B:SER180 4.7 54.0 1.0
O3A B:ADP803 4.7 56.4 1.0
CA B:ALA463 4.7 51.2 1.0
C B:ALA463 4.8 59.5 1.0
CG B:ASN238 5.0 66.7 1.0
C B:SER242 5.0 53.2 1.0

Reference:

J.J.Hartman, D.T.Hwee, J.Robert-Paganin, C.Chuang, E.R.Chin, S.Edell, K.H.Lee, R.Madhvani, P.Paliwal, J.Pernier, S.S.Sarkar, J.Schaletzky, K.Schauer, K.D.Taheri, J.Wang, E.Wehri, Y.Wu, A.Houdusse, B.P.Morgan, F.I.Malik. Aficamten Is A Small-Molecule Cardiac Myosin Inhibitor Designed to Treat Hypertrophic Cardiomyopathy Nat Cardiovasc Res V. 3 1003 2024.
ISSN: ESSN 2731-0590
DOI: 10.1038/S44161-024-00505-0
Page generated: Fri Oct 11 20:47:44 2024

Last articles

Zn in 9JYW
Zn in 9IR4
Zn in 9IR3
Zn in 9GMX
Zn in 9GMW
Zn in 9JEJ
Zn in 9ERF
Zn in 9ERE
Zn in 9EGV
Zn in 9EGW
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy